Literature DB >> 17727371

Juvenile systemic sclerosis: report of three cases and review of Japanese published work.

Kumi Aoyama1, Yayoi Nagai, Yukie Endo, Osamu Ishikawa.   

Abstract

Juvenile or childhood onset systemic sclerosis (SSc) is rare. In our department, we encountered three juvenile SSc patients among the overall 206 SSc patients. All three cases were diffuse cutaneous type SSc (dSSc) with positive antinuclear antibodies. In this report, we report the three patients and analyze clinical and serological features of 58 Japanese patients with juvenile SSc. Forty-eight patients (92.3%) were classified as dSSc and 21 out of 35 patients (60%) had anti-topoisomelase I antibodies, while anticentromere antibodies were not detected in any patients. Prevalence of lung fibrosis and scleroderma renal crisis was low, however, the rate of cardiac involvement was higher than that in adult patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727371     DOI: 10.1111/j.1346-8138.2007.00350.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  2 in total

1.  Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort.

Authors:  Ivan Foeldvari; Jens Klotsche; Kathryn S Torok; Ozgur Kasapcopur; Amra Adrovic; Valda Stanevicha; Maria Teresa Terreri; Ekaterina Alexeeva; Maria Katsicas; Rolando Cimaz; Mikhail Kostik; Thomas Lehman; Walter-Alberto Sifuentes-Giraldo; Vanessa Smith; Flavio Sztajnbok; Tadej Avcin; Maria Jose Santos; Monika Moll; Dana Nemcova; Cristina Battagliotti; Despina Eleftheriou; Mahesh Janarthanan; Tilmann Kallinich; Jordi Anton; Kirsten Minden; Susan Nielsen; Yosef Uziel; Nicola Helmus
Journal:  J Scleroderma Relat Disord       Date:  2018-08-07

Review 2.  Current developments in pediatric systemic sclerosis.

Authors:  Ivan Foeldvari
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.